Guangdong Hengqin Xinchuangyi Biopharmaceutical Co., Ltd.

Primary Objectives: 1. To evaluate the pharmacokinetic characteristics of a single oral dose of F-02-2-Na tablets in adult subjects; 2. To evaluate the safety of a single oral dose of F-02-2-Na tablets in adult subjects. Secondary Objectives: 1. To evaluate the effect of food on the pharmacokinetic characteristics of F-02-2-Na tablets; 2. To evaluate the effects of a single oral dose of F-02-2-Na tablets in adult subjects: absolute value, percentage value, and target achievement rate (≤360 μmol/L); 3. To explore uric acid excretion-related indicators (AeUR, CLUR, FEUA), the dynamic change curve of sUA (AUC), and the total 24-hour uric acid excretion.